Introduction {#sec1}
============

Interest in the potential of the indane skeleton as a valuable structure for pharmaceuticals has led to the stereoselective synthesis of compounds comprising an indane ring and its investigation using different types of reactions and starting materials.^[@ref1]−[@ref11]^ Various arylindanes have been found to be derived from propenylbenzene through biosyntheses or organic syntheses. In particular, an asarone dimer ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) found in the essential oil of *Acorus calamus* was determined to be an insect growth regulator.^[@ref12]^ Secaloside A ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), found in pollen extract, was responsible for antitumor activity.^[@ref13]^ Synthetic approaches to prepare the arylindanes from benzyl alcohols and benzhydrols with styrene derivatives have also been investigated under acidic conditions.^[@ref11],[@ref14],[@ref15]^ In these reactions, although the phenyl ring substituents were shown to significantly affect the yield and diastereoselectivity, a convincing explanation has not been provided as yet.

![Typical example of the compounds containing arylindane structure.](ao-2018-01953q_0004){#fig1}

We have developed a mass production method, starting from rice bran,^[@ref16]^ for ferulic acid **1a** ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}), which is a propenylbenzene commonly found in cereals, grasses, vegetables, and so on and has numerous biological activities for health.^[@ref17]^ As the arylindane structure is a key compound in the natural products such as secaloside A, the reaction conditions to prepare the dimers were considered worth investigating. In general, arylindane is known to have four diastereomeric racemates (α, β, γ, and δ).^[@ref18]^[Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} shows the predicted homodimers obtained from **1a**. The α form of **3a** was obtained in acidic conditions; however, the details of the reaction were not explored.^[@ref19]^ The reaction conditions used to prepare the dimer **3a** from **1a** were examined in detail, and the stereochemistries of the dimers were determined.^[@ref20]^ The structural features of the dimers and the diastereoselective formation mechanisms involved in forming the two types of racemic diastereomers (α and γ, ca. 2:1) were characterized.^[@ref20]^ Although this type of reaction is known to proceed as a formal \[3 + 2\] cycloaddition reaction,^[@ref14]^ it is suggested that the methoxy and hydroxy groups attached to the phenyl ring play an important role in the reactivity and stereoselectivity.

![Ferulic acid **1a**.](ao-2018-01953q_0005){#fig2}

![Predictable diastereomeric racemates of arylindane obtained from **1a**.](ao-2018-01953q_0006){#fig3}

In this study, the substituent effect on the \[3 + 2\] cycloaddition of ferulic acid and related compounds having hydroxy and methoxy groups at the meta and the para positions of the phenyl ring was investigated. The products yields depended on the phenyl ring substituents, and the reactivity was discussed in terms of the effect of electron-donating groups, the stability of benzylic cations, and the electrostatic potential maps of the reaction intermediates.

Results and Discussion {#sec2}
======================

The homodimerization reaction of the ferulic acid **1a** has been previously examined in detail and the reaction conditions were optimized as follows; 50--60 equiv EtOH, \>10 equiv H~2~SO~4~, \>0.5 h reaction time, and reflux temperature (80 °C).^[@ref20]^ This cyclization reaction was confirmed to occur after ethyl ferulate was produced. The cyclization reaction of ethyl ferulate as a starting material under similar acidic ethanolic conditions gave corresponding indane in a little smaller yield (28%). The feature of this reaction using ferulic acid is as follows: (a) one-pot esterification of the ferulic acid followed by dimerization of the formed ester to afford arylindane. (b) The higher amount of sulfuric acid is required for predominant formation of arylindane. Therefore, reactions of various cinnamic acids to evaluate the substituent effects were conducted to obtain the corresponding arylindanes, and the results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. In the reaction of **1a**, **1b**, **1c**, and **1f**, the arylindanes **3a**, **3b**, **3c**, and **3f** were produced in 48, 52, 10, and 28% yields, respectively. Indane was not obtained in the reaction of the other examined cinnamic acids. This dimerization reaction of the formed esters is known to proceed by a formal \[3 + 2\] cycloaddition reaction comprising the following three steps, as shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}: (I) a proton reacts with the ester **2** to produce the benzylic cation **A**^**+**^, (II) the cation **A**^**+**^ reacts with a double bond of another ester to produce a dimeric cation **B**^**+**^, and (III) the intramolecular aromatic electrophilic substitution reaction for the cyclization in the cation **B**^**+**^ occurs to produce arylindane **3**. In a previous report,^[@ref20]^ we predicted that the methoxy or hydroxy groups would play an important role in stabilizing the intermediate with a stacking configuration through OH-π or CH-π interaction. However, this prediction was not supported by the results obtained in this report. For the formation of **3**, cinnamic acid or its ester seems to need to bear two substituents, such as a methoxy group or a hydroxy group at the para and meta positions. According to the resonance structure, the methoxy or hydroxy group at the para position of the phenyl ring increases the electronic density of the double bond of the ester; hence, the reaction steps I and II likely occur to yield the indane ring. It was assumed that the para-substituent was needed to generate the benzylic cation. In fact, in the reaction of **1d**, **1g**, and **1j** without the para-substituents, no dimer was produced, and the corresponding esters were predominantly yielded. In the reaction of **1e** and **1i**, wherein the substituent existed only at the para position of the phenyl ring, the corresponding indanes were not obtained, and the dimers **6e(*****E*****)**, **6i(*****Z*****)**, and **7i** were obtained in small yields ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}).

![The isolated dimers in the reaction of **1e** and **1i**.](ao-2018-01953q_0007){#fig4}

![Mechanism of Indane Formation via Formal \[3 + 2\] Cycloaddition](ao-2018-01953q_0010){#sch1}

###### Synthesis of Esters, Indanes, and Other Dimers from Cinnamic Acid[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-01953q_0001){#fx1}

  cinnamic acids   yields (%)                                                  
  ---------------- ------------ ----- ----- ---- ------------------------ ---- ---------------------------
  **1a**           OMe          OH    H     15   48 (α: 34, γ: 14)        0    0
  **1b**           OMe          OH    OMe   17   52 (α: 36, γ: 16)        0    10 (*cis*: 5, *trans*: 5)
  **1c**           OH           OMe   H     51   10 (α: 7, γ: 3)          11   0
  **1d**           OMe          H     H     80   0                        0    0
  **1e**           H            OMe   H     72   0                        0    0
  **1f**           OMe          OMe   H     55   28 (α: 19, γ: 8, δ: 1)   3    0
  **1g**           OMe          H     OMe   92   0                        0    0
  **1h**           OMe          OMe   OMe   66   0                        14   0
  **1i**           H            OH    H     49   0                        0    0
  **1j**           H            H     H     73   0                        0    0

Reaction conditions: 80 °C, 1 h, molar ratio: cinnamic acids/H~2~SO~4~/ethanol = 1:20:55.

The substituents at the meta position of the phenyl ring acted as electron-donating groups. Thus, the electron density at the ortho and para positions was enriched to accelerate the aromatic electrophilic substitution reaction required for the cyclization reaction (step III). However, the higher effect of the electron-donating group at the meta position instead of the para position was considered to induce the aromatic electrophilic substitution reaction between the benzylic cation and the meta position of the phenyl ring of the ester. In fact, in the reaction of **1c**, **1f**, and **1h**, the dimers **4c** (11%), **4f** (3%), and **4h** (14%) were produced, respectively. In the reaction of **1h**, wherein three substituents existed, **3h** was not produced as compared with the reaction of **1b**, but **4h** was afforded in a 14% yield. The benzylic cation of **1h** was expected to react predominantly with the activated ortho position of the ester before the formation of the dimeric cation by the attack to the double bond of the ester. Alternatively, in the reaction of **1b**, the indane **3b** was obtained in 52% yield, and the dimer **5b** (*cis*/*trans* = 1:1) was also produced in 10% yield. It was assumed, as mentioned above, that the hydroxy group at the para position of **1b** activated the double bond of the ester and the ortho position of the phenyl ring was activated by the methoxy groups at the meta positions. As discussed above, para- and meta-substituents at the phenyl ring of the acids played an important role in affecting the electronic characteristics of the molecules and intermediates in steps I--III. Thus, the formation of arylindane requires the three-step reaction to occur in series.

Diastereomeric selectivities (α/γ) in the reaction of **1a**, **1b**, **1c**, and **1f** were around 2.3 and the indane α was predominantly produced. The indane β was not isolated in any of the examined reactions, and the indane **3f(δ)** was isolated only in the reaction of **1f** in 1% yield. [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} shows the partial ^1^H NMR spectra of **3f(α)**, **3f(γ)**, and **3f(δ)**. Although the spectral pattern was clearly different for each isomer, the spectral features of these isomers were the doublet signals of the H~c~ protons. The molecular structure of the indane **3c(α)** and the dimer **5b** (*trans*) were determined via X-ray diffraction (see [Figure S75](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01953/suppl_file/ao8b01953_si_001.pdf)). Two enantiomers of **3c(α)** were packed into the crystal lattice (see [Figure S76](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01953/suppl_file/ao8b01953_si_001.pdf)).

![Partial ^1^H NMR spectra of **3f(α)**, **3f(γ)**, and **3f(δ)**.](ao-2018-01953q_0008){#fig5}

The crossed dimerization between **1a** and **1b** was investigated to clarify the reactivities of some cinnamic acids ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Although a complex mixture was obtained from the reaction, the products were isolated using preparative high performance liquid chromatography (HPLC) as much as possible. As a result, the crossed dimers **8ab** and **9ab** were obtained in 16 and 17% yields, respectively, and the homodimers **3a** and **3b** were produced in 28 and 31% yields, respectively ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). This was explained by the esters **2a** and **2b** having a similar reactivity. Next, the two benzylic cations generated from each ester that reacted with the reactive double bonds of both esters were cyclized at the activated ortho position of the intermediates. This mechanism coincided with the reactivity of the acids mentioned above. In the cross-dimerization of **1a** with **1d**, the dimers **8ad** and **9ad** were not formed, and only **3a** was obtained. This showed that the crossed dimerization of **1a** did not proceed with the other acids that did not form the corresponding indane.

![Crossed Dimerization Between **1a** and **1b**](ao-2018-01953q_0011){#sch2}

###### Synthesis of Esters and Indanes by Crossed Dimerization Between **1a** and Other Cinnamic Acids[a](#t2fn1){ref-type="table-fn"}

                yields (%)                                                                   
  ------------- ------------ ---- ------------------- ------------------- ------------------ ------------------
  **1a + 1b**   32           28   28 (α: 20, γ: 8)    31 (α: 21, γ: 10)   16 (α: 12, γ: 4)   17 (α: 12, γ: 5)
  **1a + 1d**   46           86   39 (α: 28, γ: 11)   0                   0                  0

Reaction conditions: 80 °C, 1 h, molar ratio: cinnamic acids/H~2~SO~4~/ethanol = 1:20:55.

To investigate the reactivity of the formed esters **2a**--**j**, the energy difference (Δ*E*) between each ester and the corresponding benzyl cation generated by the acid was calculated, as shown in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. In the case of the esters **2a**, **2b**, **2c**, and **2f** that produced the corresponding indanes, the Δ*E* values were relatively low (\<−170 kJ/mol), suggesting that the benzylic cations would be likely generated. However, the esters **2e**, **2h** and **2i**, having low Δ*E* values, did not produce the corresponding indanes. For **2e** and **2i**, the benzylic cation might have been produced, but the cyclization reaction was unfavorable due to a lack of reactivity at the ortho position of the phenyl ring, as mentioned above. In the case of **2h**, **4h** was produced instead of indane. The reactivity of the ortho position of the phenyl ring of **2h** was considered to be higher than that of the double bond owing to two substituents at the meta position, whereas the benzyl cation was also produced. To discuss these results, the molecular electrostatic potential maps were calculated, and the results for the esters **2a**, **2b**, and **2h** are shown in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. The negative regions (in red) are located on the aromatic ring, double bond, and oxygen atoms in each ester, whereas the positive regions (in blue) are located on the methyl groups in the methoxy groups of **2a** and **2b**. There was no positive region on the methoxy groups in **2h**. Therefore, for **2a** and **2b**, the benzyl cation might be favored to attack the double bond due to electrostatic repulsion between the positive charges located around the aromatic ring. Alternatively, the benzyl cation of **2h** might attack the aromatic ring without repulsive interaction.

![Molecular electrostatic potential map for **2a**, **2b**, and **2h** (−40 to 70 eV: isovalue 0.0001).](ao-2018-01953q_0009){#fig6}

###### Energy Difference (Δ*E*) Between Each Ester and Corresponding Benzyl Cation

![](ao-2018-01953q_0002){#fx2}

  esters   Δ*E* (kJ/mol)   esters   Δ*E* (kJ/mol)
  -------- --------------- -------- ---------------
  **2a**   --183.375       **2f**   --193.289
  **2b**   --183.670       **2g**   --142.888
  **2c**   --173.445       **2h**   --189.621
  **2d**   --136.168       **2i**   --190.364
  **2e**   --177.155       **2j**   --129.227

Conclusions {#sec3}
===========

Homodimers with arylindane skeletons were obtained from ferulic acid **1a** in an acidic ethanol solution via a formal \[3 + 2\] cycloaddition reaction. Various cinnamic acids having hydroxy and/or methoxy groups at various positions on the phenyl ring were also investigated. This reaction arose from the protonation of the first produced ester to afford a benzylic cation, which reacted with another ester to afford a new benzylic cation, which then cyclized to produce the homodimer. The reactivities of the intermediates, such as the esters and cations, were interpreted by studying the effects of the electron-donating groups, the energy difference between the ester and the benzylic cation, and the molecular electrostatic potential map. It was suggested that the para-substituent promoted the formation of the benzylic cation and the coupling reaction between the cation and the double bond of another ester, and that the meta-substituent accelerated the cyclization process through electrophilic aromatic substitution. The calculation of the stability of the benzyl cations and the electrostatic potential map of the esters revealed that the reactivity of the intermediates depended on the substituents of the phenyl ring.

Experimental Section {#sec4}
====================

All the solvents and reagents were obtained commercially and used without further purification. ^1^H NMR, ^13^C NMR, and two-dimensional NMR spectra were recorded on a Bruker Avance-400 instrument using tetramethylsilane as the internal standard. The Fourier-transform infrared spectra were recorded using a single reflection horizontal attenuated total reflectance (ATR). High resolution mass spectrometry HRMS (electrospray ionization time-of-flight, ESI-TOF) spectra were measured in either negative or positive ionization mode, and the data were reported in the form of *m*/*z* values. Preparative HPLC equipped with an octadecylsilyl column (250 × 20 mm, 5 μm) using MeOH/H~2~O (60:40) as the eluent was used to isolate the product mixtures. Melting points were determined by using a differential scanning calorimeter, and the peak top temperatures were reported. The isolated yields for the esters were reported, and the yields of the dimers were estimated from the ^1^H NMR spectra of the mixtures. The esters **2a**--**j** were identified via ^1^H and ^13^C NMR spectra (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01953/suppl_file/ao8b01953_si_001.pdf)).

Homodimerization of **1a** {#sec4.1}
--------------------------

To a solution of **1a** (300 mg, 1.54 mmol) in ethanol (4.96 mL, 85 mmol), which was cooled in an ice bath and kept under an Ar atmosphere, was added sulfuric acid (1.65 mL, 31 mmol). The mixture was stirred for 1 h at 80 °C, followed by the addition of ice-water to stop the reaction. The products were extracted using dichloromethane, and the extract was first washed with water, then water saturated with sodium bicarbonate, and finally with water again. The organic portion was dried over MgSO~4~. After evaporating the solvent, the product was purified through an SiO~2~ column (1:1 EtOAc/hexane as the eluent), which afforded 51 mg of **2a** (15%, isolated), the indane mixture **3a(α)** (34%), and **3a(γ)** (14%). The isomers were isolated from the mixture using a preparative HPLC for characterization.

### (1*S*,2*R*,3*R*)-Ethyl {#sec4.1.1}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3a(α)**:^[@ref20]^ 34.3% of **3a(α)**.

### (1*S*,2*S*,3*S*)-Ethyl {#sec4.1.2}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3a(γ)**:^[@ref20]^ 14.3% of **3a(γ)**.

Homodimerization of **1b** {#sec4.2}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1b** (346 mg, 15.4 mmol) to afford 67 mg of **2b** (17%, isolated), **3b(α)** (36%), **3b(γ)** (16%), **5b** (*cis*) (5%), and **5b** (*trans*) (5%).

### (1*S*,2*R*,3*R*)-Ethyl {#sec4.2.1}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-4,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3b(α)**: colorless oil; IR (ATR) ν~max~ 3435, 1724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.24 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.51 (dd, 1H, *J* = 16.3, 8.0 Hz, CH~2~), 2.60 (dd, 1H, *J* = 16.1, 7.0 Hz, CH~2~), 3.39 (t, 1H, *J* = 7.8 Hz, CH), 3.48 (s, 3H, OCH~3~), 3.81 (s, 6H, OCH~3~), 3.88 (s, 3H, OCH~3~), 3.95--4.03 (m, 1H, CH), 4.11 (q, 2H, *J* = 7.3 Hz, C*H*~2~CH~3~), 4.15 (q, 2H, *J* = 7.3 Hz, C*H*~2~CH~3~), 4.75 (d, 1H, *J* = 7.5 Hz, CH), 5.40 (s, 1H, OH), 5.50 (s, 1H, OH), 6.39 (s, 2H, ArH), 6.57 (s, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.22, 14.24, 37.0, 42.5, 50.8, 56.31, 56.34, 58.7, 60.0, 60.6, 60.7, 102.1, 104.4, 127.6, 133.4, 134.4, 135.4, 137.9, 143.6, 146.9, 147.7, 172.2, 172.7; HRMS (ESI-TOF) calcd for C~26~H~31~O~10~ \[M -- H\]^−^ 503.1923, found 503.1931.

### (1*S*,2*S*,3*S*)-Ethyl {#sec4.2.2}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-4,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3b(γ)**: colorless oil; IR (ATR) ν~max~ 3431, 1728 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.25 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.72 (dd, 1H, *J* = 15.9, 7.3 Hz, CH~2~), 2.84 (dd, 1H, *J* = 15.8, 6.0 Hz, CH~2~), 3.01 (t, 1H, *J* = 7.4 Hz, CH), 3.45 (s, 3H, OCH~3~), 3.78--3.85 (m, 1H, CH), 3.83 (s, 6H, OCH~3~), 3.89 (s, 3H, OCH~3~), 4.10--4.22 (m, 4H, C*H*~2~CH~3~), 4.65 (d, 1H, *J* = 7.3 Hz, CH), 5.41 (s, 1H, OH), 5.48 (s, 1H, OH), 6.43 (s, 2H, ArH), 6.53 (d, 1H, *J* = 0.8 Hz, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.25, 14.32, 39.9, 44.3, 52.6, 56.32, 56.34, 59.8, 60.6, 60.78, 60.82, 101.5, 104.4, 127.7, 133.4, 135.0, 135.8, 137.9, 143.4, 146.9, 148.0, 171.9, 174.2; HRMS (ESI-TOFF) calcd for C~26~H~31~O~10~ \[M -- H\]^−^ 503.1923, found 503.1906.

### Diethyl {#sec4.2.3}

2,2′-((9*R*,10*R*)-2,6-Dihydroxy-1,3,5,7-tetramethoxy-9,10-dihydroanthracene-9,10-diyl)diacetate **5b** (9, 10-*cis*): colorless solid, mp 188 °C; IR (ATR) ν~max~ 3414, 1717, 1721 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.22 (t, 6H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.41 (dd, 2H, *J* = 14.9, 10.2 Hz, CH~2~), 2.82 (dd, 2H, *J* = 14.8, 4.0 Hz, CH~2~), 3.87 (s, 6H, OCH~3~), 3.97 (s, 6H, OCH~3~), 4.08--4.17 (m, 4H, C*H*~2~CH~3~), 4.69 (dd, 2H, *J* = 10.0, 4.0 Hz, CH), 5.45 (s, 2H, OH), 6.76 (s, 2H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.2, 35.6, 45.3, 56.2, 60.4, 60.6, 106.4, 125.2, 130.0, 137.1, 143.7, 146.3, 172.3; HRMS (ESI-TOFF) calcd for C~26~H~31~O~10~ \[M -- H\]^−^ 503.1923, found 503.1961.

### Diethyl {#sec4.2.4}

2,2′-((9*R*,10*S*)-2,6-Dihydroxy-1,3,5,7-tetramethoxy-9,10-dihydroanthracene-9,10-diyl)diacetate **5b** (9, 10-*trans*): colorless solid, mp 194 °C (recrystallized from hexane/EtOAc); IR (ATR) ν~max~ 3447, 3462, 1734 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.18 (t, 6H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.64 (dd, 2H, *J* = 16.1, 6.5 Hz, CH~2~), 2.84 (dd, 2H, *J* = 16.1, 3.8 Hz, CH~2~), 3.87 (s, 6H, OCH~3~), 3.94 (s, 6H, OCH~3~), 4.02--4.10 (m, 4H, C*H*~2~CH~3~), 4.67 (dd, 2H, *J* = 6.1, 3.6 Hz, CH), 5.44 (s, 2H, OH), 6.68 (s, 2H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.2, 34.3, 46.1, 56.1, 60.2, 60.7, 105.0, 123.2, 129.3, 137.1, 143.9, 146.6, 173.0; HRMS (ESI-TOFF) calcd for C~26~H~31~O~10~ \[M -- H\]^−^ 503.1923, found 503.1907.

Homodimerization of **1c** {#sec4.3}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1c** (300 mg, 15.4 mmol) to afford 175 mg of **2c** (51%, isolated), **3c(α)** (7%), **3c(γ)** (3%), and 38 mg of **4c** (11%).

### (1*S*,2*R*,3*R*)-Ethyl {#sec4.3.1}

1-(2-Ethoxy-2-oxoethyl)-6-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-5-methoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3c(α)**: colorless solid, mp 175.9 °C (recrystallized from hexane/EtOAc); IR (ATR) ν~max~ 3347, 1724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.22 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.44 (dd, 1H, *J* = 15.9, 8.4 Hz, CH~2~), 2.60 (dd, 1H, *J* = 15.8, 6.8 Hz, CH~2~), 3.39 (dd, 1H, *J* = 9.5, 8.0 Hz, CH), 3.75 (s, 3H, OCH~3~), 3.88 (s, 3H, OCH~3~), 3.93--3.99 (m, 1H, CH), 4.06--4.19 (m, 4H, C*H*~2~CH~3~), 4.61 (d, 1H, *J* = 9.5 Hz, CH), 5.54 (s, 1H, OH), 5.55 (s, 1H, OH), 6.38 (d, 1H, *J* = 0.5 Hz, ArH), 6.71--6.80 (m, 4H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.19, 14.23, 36.9, 42.1, 51.4, 56.0, 56.1, 58.5, 60.5, 60.6, 107.5, 109.9, 110.6, 114.5, 120.2, 135.6, 136.2, 136.4, 145.2, 145.5, 145.7, 146.5, 172.1, 172.5; HRMS (ESI-TOFF) calcd for C~24~H~27~O~8~ \[M -- H\]^−^ 443.1711, found 443.1709.

### (1*S*,2*S*,3*S*)-Ethyl {#sec4.3.2}

1-(2-Ethoxy-2-oxoethyl)-6-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-5-methoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3c(γ)**: ^1^H NMR (400 MHz, CDCl~3~) δ 1.22 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.71 (dd, 1H, *J* = 15.9, 7.0 Hz, CH~2~), 2.84 (dd, 1H, *J* = 16.1, 6.1 Hz, CH~2~), 2.96 (t, 1H, *J* = 9.2 Hz, CH), 3.74 (s, 3H, OCH~3~), 3.79--3.86 (m, 1H, CH), 3.89 (s, 3H, OCH~3~), 4.10--4.21 (m, 4H, C*H*~2~CH~3~), 4.47 (d, 1H, *J* = 9.3 Hz, CH), 5.56 (s, 1H, OH), 5.57 (s, 1H, OH), 6.36 (d, 1H, *J* = 0.8 Hz, ArH), 6.70--6.81 (m, 4H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.2, 14.3, 39.3, 43.7, 53.6, 56.0, 56.2, 60.58, 60.64, 61.3, 107.2, 109.0, 110.6, 114.5, 120.1, 135.5, 136.0, 136.8, 145.4, 145.6, 145.7, 146.4, 172.0, 173.9; HRMS (ESI-TOFF) calcd for C~24~H~27~O~8~ \[M -- H\]^−^ 443.1711, found 443.1684.

### (*E*)-Ethyl {#sec4.3.3}

3-(2-(3-Ethoxy-1-(3-hydroxy-4-methoxyphenyl)-3-oxopropyl)-5-hydroxy-4-methoxyphenyl)propenoate **4c**: colorless oil; IR (ATR) ν~max~ 3426, 1701, 1722 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.13 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.33 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.94 (dd, 1H, *J* = 15.3, 8.5 Hz, CH~2~), 3.01 (dd, 1H, *J* = 15.1, 7.5 Hz, CH~2~), 3.83 (s, 3H, OCH~3~), 3.87 (s, 3H, OCH~3~), 4.01--4.06 (m, 2H, C*H*~2~CH~3~), 4.20--4.26 (m, 2H, C*H*~2~CH~3~), 4.84 (t, 1H, *J* = 8.0 Hz, CH), 5.57 (s, 1H, OH), 5.59 (s, 1H, OH), 6.17 (d, 1H, *J* = 15.6 Hz, CH=CH), 6.70--6.76 (m, 4H, ArH), 7.11 (s, 1H, ArH), 8.08 (d, 1H, *J* = 15.8 Hz, CH=CH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.1, 14.3, 41.4, 41.6, 55.9, 56.0, 60.3, 60.6, 109.4, 110.6, 112.7, 113.7, 118.4, 119.1, 126.4, 135.4, 136.5, 141.4, 144.3, 145.2, 145.6, 148.2, 167.1, 171.4; HRMS (ESI-TOFF) calcd for C~24~H~27~O~8~ \[M -- H\]^−^ 443.1711, found 443.1669.

Homodimerization of **1d** {#sec4.4}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1d** (275 mg, 15.4 mmol) to afford 253 mg of **2d** (80%, isolated).

Homodimerization of **1e** {#sec4.5}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1e** (275 mg, 15.4 mmol) to afford 228 mg of **2e** (72%, isolated) and **6e** (5%).

### (*E*)-Diethyl {#sec4.5.1}

2-(4-Methoxybenzylidene)-3-(4-methoxyphenyl)pentanedioate **6e(*****E*****)**. colorless oil; IR (ATR) ν~max~ 1709, 1728 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.00 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.15 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.88 (dd, 1H, *J* = 15.3, 8.8 Hz, CH~2~), 3.02 (dd, 1H, *J* = 15.3, 7.3 Hz, CH~2~), 3.78 (s, 3H, OCH~3~), 3.79 (s, 3H, OCH~3~), 4.00 (q, 2H, *J* = 7.2 Hz, C*H*~2~CH~3~), 4.06 (q, 2H, *J* = 7.2 Hz, C*H*~2~CH~3~), 4.31 (m, 1H, CH), 6.56 (s, 1H, CH=C), 6.79--6.85 (m, 4H, ArH), 7.16--7.22 (m, 4H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 13.8, 14.2, 39.3, 45.5, 55.2, 55.3, 60.5, 60.6, 113.6, 113.9, 128.3, 129.1, 129.7, 131.7, 132.5, 135.2, 158.5, 159.4, 169.3, 171.6; HRMS (ESI-TOFF) calcd for C~24~H~28~NaO~6~ \[M + Na\]^+^ 435.1778, found 435.1749.

Homodimerization of **1f** {#sec4.6}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1f** (322 mg, 15.4 mmol) to afford 201 mg of **2f** (55%, isolated), **3f(α)** (19%), **3f(γ)** (8%), **3f(δ)** (1%), and **4f** (3%).

### (1*R*,2*R*,3*S*)-Ethyl {#sec4.6.1}

1-(3,4-Dimethoxyphenyl)-3-(2-ethoxy-2-oxoethyl)-5,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3f(α)**: colorless oil; IR (ATR) ν~max~ 1717 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.24 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.46 (dd, 1H, *J* = 16.1, 8.8 Hz, CH~2~), 2.63 (dd, 1H, *J* = 16.1, 6.3 Hz, CH~2~), 3.42 (dd, 1H, *J* = 9.9, 8.2 Hz, CH), 3.73 (s, 3H, OCH~3~), 3.81 (s, 3H, OCH~3~), 3.86 (s, 3H, OCH~3~), 3.88 (s, 3H, OCH~3~), 3.97--4.03 (m, 1H, CH), 4.08--4.17 (m, 4H, C*H*~2~CH~3~), 4.69 (d, 1H, *J* = 10.0 Hz, CH), 6.41 (s, 1H, ArH), 6.71 (d, 1H, *J* = 1.8 Hz, ArH), 6.79--6.84 (m, 3H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.22, 14.24, 36.9, 42.3, 51.5, 55.9, 56.0, 58.9, 60.5, 60.7, 107.2, 107.9, 111.2, 111.4, 120.8, 135.2, 135.8, 136.1, 148.0, 148.6, 149.0, 149.1, 172.3, 172.5; HRMS (ESI-TOFF) calcd for C~26~H~32~NaO~8~ \[M + Na\]^+^ 495.1989, found 495.1948.

### (1*S*,2*S*,3*S*)-Ethyl {#sec4.6.2}

1-(3,4-Dimethoxyphenyl)-3-(2-ethoxy-2-oxoethyl)-5,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3f(γ)**: colorless oil; IR (ATR) ν~max~ 1724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.23 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.27 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.78 (dd, 1H, *J* = 15.9, 6.9 Hz, CH~2~), 2.89 (dd, 1H, *J* = 15.9, 6.1 Hz, CH~2~), 3.02 (t, 1H, *J* = 9.2 Hz, CH), 3.73 (s, 3H, OCH~3~), 3.82 (s, 3H, OCH~3~), 3.85--3.91 (m, 1H, CH), 3.88 (s, 3H, OCH~3~), 3.89 (s, 3H, OCH~3~), 4.12--4.20 (m, 4H, C*H*~2~CH~3~), 4.54 (d, 1H, *J* = 9.3 Hz, CH), 6.40 (d, 1H, *J* = 0.8 Hz, ArH), 6.72--6.84 (m, 4H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.25, 14.29, 39.3, 43.9, 53.7, 55.9, 56.0, 56.1, 60.6, 60.7, 61.3, 106.2, 107.7, 111.2, 111.4, 120.7, 135.1, 135.9, 136.0, 148.0, 148.9, 149.0, 149.1, 172.0, 173.9; HRMS (ESI-TOFF) calcd for C~26~H~32~NaO~8~ \[M + Na\]^+^ 495.1989, found 495.1940.

### (1*R*,2*S*,3*S*)-Ethyl {#sec4.6.3}

1-(3,4-Dimethoxyphenyl)-3-(2-ethoxy-2-oxoethyl)-5,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **3f(δ)**: colorless oil; IR (ATR) ν~max~ 1728, 1732 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 0.96 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.25 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.60 (dd, 1H, *J* = 14.8, 7.5 Hz, CH~2~), 2.77 (dd, 1H, *J* = 15.1, 6.0 Hz, CH~2~), 3.55 (dd, 1H, *J* = 9.3, 8.3 Hz, CH), 3.64--3.74 (m, 1H, C*H*~2~CH~3~), 3.76--3.87 (m, 1H, C*H*~2~CH~3~), 3.76 (s, 3H, OCH~3~), 3.78 (s, 3H, OCH~3~), 3.82 (s, 3H, OCH~3~), 3.90 (s, 3H, OCH~3~), 4.09--4.19 (m, 3H, CH and C*H*~2~CH~3~), 4.67 (d, 1H, *J* = 9.5 Hz, CH), 6.50--6.53 (m, 2H, ArH), 6.54 (s, 1H, ArH), 6.71--6.73 (m, 1H, ArH), 6.80 (s, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.0, 14.2, 39.3, 42.2, 52.7, 55.8, 55.97, 56.00, 56.9, 60.3, 60.6, 106.4, 107.7, 110.8, 112.1, 121.0, 133.6, 135.7, 135.8, 148.0, 148.5, 149.0, 149.1, 172.0, 172.2; HRMS (ESI-TOFF) calcd for C~26~H~32~NaO~8~ \[M + Na\]^+^ 495.1989, found 495.1953.

### (*E*)-Ethyl {#sec4.6.4}

3-(2-(1-(3,4-Dimethoxyphenyl)-3-ethoxy-3-oxopropyl)-4,5-dimethoxyphenyl)propenoate **4f**: IR (ATR) ν~max~ 1705, 1728 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.14 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.33 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.98 (dd, 1H, *J* = 15.2, 8.1 Hz, CH~2~), 3.05 (dd, 1H, *J* = 15.3, 7.7 Hz, CH~2~), 3.82 (s, 3H, OCH~3~), 3.83 (s, 3H, OCH~3~), 3.87 (s, 3H, OCH~3~), 3.88 (s, 3H, OCH~3~), 4.01--4.08 (m, 2H, C*H*~2~CH~3~), 4.22--4.27 (q, 2H, *J* = 7.2 Hz, C*H*~2~CH~3~), 4.90 (t, 1H, *J* = 8.0 Hz, CH), 6.21 (d, 1H, *J* = 15.6 Hz, CH=CH), 6.68--6.78 (m, 4H, ArH), 7.03 (s, 1H, ArH), 8.14 (d, 1H, *J* = 15.8 Hz, CH=CH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.1, 14.4, 41.3, 41.9, 55.8, 55.86, 55.89, 56.0, 60.4, 60.6, 109.4, 110.0, 111.19, 111.24, 118.0, 119.3, 125.6, 135.6, 136.2, 141.6, 147.6, 148.9, 150.7, 167.0, 171.4; HRMS (ESI-TOFF) calcd for C~26~H~32~NaO~8~ \[M + Na\]^+^ 495.1989, found 495.1952.

Homodimerization of **1g** {#sec4.7}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1g** (322 mg, 15.4 mmol) to afford 336 mg of **2g** (92%, isolated).

Homodimerization of **1h** {#sec4.8}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1h** (368 mg, 15.4 mmol) to afford 270 mg of **2h** (66%, isolated) and **4h** (14%).

### (*E*)-Ethyl {#sec4.8.1}

3-(2-(3-Ethoxy-3-oxo-1-(3,4,5-trimethoxyphenyl)propyl)-3,4,5-trimethoxyphenyl)acrylate **4h**: colorless oil; IR (ATR) ν~max~ 1709, 1728 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.16 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.33 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 3.11 (dd, 1H, *J* = 15.3, 8.0 Hz, CH~2~), 3.27 (dd, 1H, *J* = 15.3, 7.3 Hz, CH~2~), 3.57 (s, 3H, OCH~3~), 3.79 (s, 6H, OCH~3~), 3.80 (s, 3H, OCH~3~), 3.86 (s, 3H, OCH~3~), 3.87 (s, 3H, OCH~3~), 4.00--4.12 (m, 2H, C*H*~2~CH~3~), 4.25 (q, 2H, *J* = 7.2 Hz, C*H*~2~CH~3~), 4.99 (t, 1H, *J* = 7.5 Hz, CH), 6.22 (d, 1H, *J* = 15.8 Hz, CH=CH), 6.44 (s, 2H, ArH), 6.79 (s, 1H, ArH), 8.13 (d, 1H, *J* = 15.6 Hz, CH=CH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.2, 14.3, 38.4, 38.9, 55.9, 56.1, 60.50, 60.54, 60.7, 60.9, 104.6, 105.9, 120.4, 129.5, 129.8, 136.4, 138.8, 143.4, 144.0, 152.4, 152.6, 153.0, 166.6, 172.3; HRMS (ESI-TOFF) calcd for C~28~H~36~NaO~10~ \[M + Na\]^+^ 555.2201, found 555.2143.

Homodimerization of **1i** {#sec4.9}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1i** (254 mg, 15.4 mmol) to afford 146 mg of **2i** (49%, isolated), **6i** (3%), and **7i** (2%).

### (*Z*)-Diethyl {#sec4.9.1}

2-(4-Hydroxybenzylidene)-3-(4-hydroxyphenyl)pentanedioate **6i(*****Z*****)**: IR (ATR) ν~max~ 3362, 1701 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.18 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.23 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 3.10 (dd, 1H, *J* = 15.3, 7.3 Hz, CH~2~), 3.27 (dd, 1H, *J* = 15.3, 8.0 Hz, CH~2~), 4.04--4.18 (m, 4H, C*H*~2~CH~3~), 4.85 (t, 1H, *J* = 7.7 Hz, CH), 5.66 (brs, 2H, OH), 6.67--6.70 (m, 2H, ArH), 6.78--6.81 (m, 2H, ArH), 7.03--7.07 (m, 2H, ArH), 7.30--7.34 (m, 2H, ArH), 7.75 (s, 1H, CH=C); ^13^C NMR (100 MHz, CDCl~3~) δ 14.08, 14.12, 38.0, 38.3, 60.7, 60.8, 115.1, 115.6, 127.4, 128.4, 131.0, 132.5, 133.6, 140.8, 154.2, 156.4, 167.6, 173.3; HRMS (ESI-TOFF) calcd for C~22~H~23~O~6~ \[M -- H\]^−^ 383.1500, found 383.1524.

### (*E*)-Ethyl {#sec4.9.2}

3-(3-(3-Ethoxy-1-(4-hydroxyphenyl)-3-oxopropyl)-4-hydroxyphenyl)propenoate **7i**: IR (ATR) ν~max~ 3335, 1680, 1684 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.18 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.32 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 3.03--3.14 (m, 2H, CH~2~), 4.06--4.14 (m, 2H, C*H*~2~CH~3~), 4.24 (q, 2H, *J* = 7.2 Hz, C*H*~2~CH~3~), 4.76 (dd, 1H, *J* = 8.7, 6.7 Hz, CH), 5.02 (brs, 1H, OH), 6.21 (d, 1H, *J* = 16.1 Hz, CH=CH), 6.54 (brs, 1H, OH), 6.76--6.79 (m, 2H, ArH), 6.85 (d, 1H, *J* = 8.5 Hz), 7.10--7.14 (m, 2H, ArH), 7.18 (d, 1H, *J* = 2.0 Hz, ArH), 7.29 (dd, 1H, *J* = 8.5, 2.0 Hz, ArH), 7.54 (d, 1H, *J* = 16.1 Hz, CH=CH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.0, 14.4, 28.6, 40.1, 60.4, 61.3, 115.58, 115.63, 117.8, 127.5, 127.7, 129.0, 131.4, 134.5, 144.5, 154.4, 155.6, 167.4, 173.5; HRMS (ESI-TOFF) calcd for C~22~H~23~O~6~ \[M -- H\]^−^ 383.1500, found 383.1532.

Homodimerization of **1j** {#sec4.10}
--------------------------

The same procedure described for the reaction of **1a** was carried out with **1j** (229 mg, 15.4 mmol) to afford 200 mg of **2j** (73%, isolated).

Crossed Dimerization of **1a** and **1b** {#sec4.11}
-----------------------------------------

To a solution of **1a** (150 mg, 0.77 mmol) and **1b** (173 mg, 0.77 mmol) in ethanol (4.96 mL, 85 mmol), which was cooled in an ice bath and kept under an Ar atmosphere, was added sulfuric acid (1.65 mL, 30 mmol). The mixture was stirred for 1 h at 80 °C and then ice-water was added to stop the reaction. The similar work-up process described for the homodimerization of **1a** was carried out to afford 54 mg of **2a** (32%, isolated), 55 mg of **2b** (28%, isolated), **3a** (28%), **3b** (31%), **8ab(α)** (12%), **8ab(γ)** (4%), **9ab(α)** (12%), and **9ab(γ)** (5%).

### (1*S*,2*R*,3*R*)-Ethyl {#sec4.11.1}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-6-methoxy-2,3-dihydro-1*H*-indene-2-carboxylate **8ab(α)**: IR (ATR) ν~max~ 3395, 1724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.24 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.44 (dd, 1H, *J* = 16.1, 8.8 Hz, CH~2~), 2.62 (dd, 1H, *J* = 16.1, 6.3 Hz, CH~2~), 3.42 (dd, 1H, *J* = 10.2, 8.2 Hz, CH), 3.82 (s, 6H, OCH~3~), 3.87 (s, 3H, OCH~3~), 3.93--4.01 (m, 1H, CH), 4.08--4.19 (m, 4H, C*H*~2~CH~3~), 4.62 (d, 1H, *J* = 10.3 Hz, CH), 5.44 (s, 1H, OH), 5.55 (s, 1H, OH), 6.43 (s, 2H, ArH), 6.48 (d, 1H, *J* = 0.8 Hz, ArH), 6.79 (s, 1H, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.2, 14.3, 36.9, 42.2, 51.8, 56.1, 56.3, 58.6, 60.5, 60.7, 105.1, 106.6, 110.0, 133.5, 133.6, 135.1, 136.9, 145.6, 146.1, 147.0, 172.3, 172.5; HRMS (ESI-TOFF) calcd for C~25~H~29~O~9~ \[M -- H\]^−^ 473.1817, found 473.1829.

### (1*S*,2*S*,3*S*)-Ethyl {#sec4.11.2}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-6-methoxy-2,3-dihydro-1*H*-indene-2-carboxylate **8ab(γ)**: IR (ATR) ν~max~ 3435, 1722 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.23 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.27 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.78 (dd, 1H, CH~2~, *J* = 16.1, 6.8 Hz), 2.87 (dd, 1H, *J* = 15.8, 6.3 Hz, CH~2~), 3.00 (t, 1H, *J* = 9.3 Hz, CH), 3.79--3.86 (m, 1H, CH), 3.83 (s, 6H, OCH~3~), 3.89 (s, 3H, OCH~3~), 4.12--4.21 (m, 4H, C*H*~2~CH~3~), 4.47 (d, 1H, *J* = 9.3 Hz, CH), 5.45 (s, 1H, OH), 5.54 (s, 1H, OH), 6.43 (s, 2H, ArH), 6.48 (d, 1H, *J* = 1.0 Hz, ArH), 6.71 (d, 1H, *J* = 0.8 Hz, ArH); ^13^C NMR (100 MHz, CDCl~3~) δ 14.26, 14.31, 39.3, 43.9, 54.1, 56.1, 56.3, 60.6, 60.7, 61.2, 105.1, 105.5, 110.8, 133.7, 134.2, 134.5, 136.8, 145.5, 146.4, 147.1, 172.1, 173.9; HRMS (ESI-TOFF) calcd for C~25~H~29~O~9~ \[M -- H\]^−^ 473.1817, found 473.1819.

### (1*S*,2*R*,3*R*)-Ethyl {#sec4.11.3}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-4,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **9ab(α)**: IR (ATR) ν~max~ 3428, 1724 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.24 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.52 (dd, 1H, *J* = 16.2, 8.0 Hz, CH~2~), 2.60 (dd, 1H, *J* = 16.1, 7.0 Hz, CH~2~), 3.39 (dd, 1H, *J* = 8.2, 7.4 Hz, CH), 3.47 (s, 3H, OCH~3~), 3.82 (s, 3H, OCH~3~), 3.87 (s, 3H, OCH~3~), 3.97--4.03 (m, 1H, CH), 4.08--4.17 (m, 4H, C*H*~2~CH~3~), 4.76 (d, 1H, *J* = 7.3 Hz, CH), 5.49 (s, 1H, OH), 5.50 (s, 1H, OH), 6.56 (s, 1H, ArH), 6.65--6.68 (m, 2H, Ar), 6.80--6.83 (m, 1H, Ar); ^13^C NMR (100 MHz, CDCl~3~) δ 14.20, 14.24, 36.9, 42.5, 50.4, 56.0, 56.3, 58.7, 59.9, 60.4, 60.6, 102.2, 104.9, 110.3, 114.1, 120.4, 127.9, 134.6, 135.4, 137.9, 144.3, 146.4, 147.6, 172.2, 172.7; HRMS (ESI-TOFF) calcd for C~25~H~29~O~9~: \[M -- H\]^−^ 473.1817, found 473.1821.

### (1*S*,2*S*,3*S*)-Ethyl {#sec4.11.4}

1-(2-Ethoxy-2-oxoethyl)-5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-4,6-dimethoxy-2,3-dihydro-1*H*-indene-2-carboxylate **9ab(γ)**: IR (ATR) ν~max~ 3424, 1722 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~) δ 1.25 (t, 3H, *J* = 7.0 Hz, CH~2~C*H*~3~), 1.26 (t, 3H, *J* = 7.2 Hz, CH~2~C*H*~3~), 2.70 (dd, 1H, *J* = 15.8, 7.3 Hz, CH~2~), 2.84 (dd, 1H, *J* = 16.0, 5.7 Hz, CH~2~), 3.00 (t, 1H, *J* = 7.5 Hz, CH), 3.43 (s, 3H, OCH~3~), 3.77--3.83 (m, 1H, CH), 3.83 (s, 3H, OCH~3~), 3.89 (s, 3H, OCH~3~), 4.12--4.22 (m, 4H, C*H*~2~CH~3~), 4.65 (d, 1H, *J* = 7.5 Hz, CH), 5.48 (s, 1H, OH), 5.50 (s, 1H, OH), 6.53 (d, 1H, *J* = 0.8 Hz, ArH), 6.66--6.72 (m, 2H, ArH), 6.83 (d, 1H, *J* = 8.0 Hz, ArH, *J* = 8.0 Hz); ^13^C NMR (100 MHz, CDCl~3~) δ 14.2, 14.3, 29.7, 39.9, 44.3, 52.2, 55.9, 56.3, 59.7, 60.6, 60.8, 101.5, 110.2, 114.1, 120.3, 127.9, 134.9, 136.5, 137.9, 143.3, 144.2, 146.4, 147.9, 172.0, 174.2; HRMS (ESI-TOFF) calcd for C~25~H~29~O~9~ \[M -- H\]^−^ 473.1817, found 473.1812.

Computational Methods {#sec5}
=====================

The energy difference between each ester and the corresponding benzyl cation as well as the molecular electrostatic potential map for each ester was calculated as follows. Conformational searches were performed with SPARTAN 16 using an MMFF force field. The obtained stable conformers were optimized using density functional theory calculations at the ωB97XD/6-31+G(d) level using SPARTAN 16. The partial charges and molecular surfaces for each ester were calculated using SPARTAN 16 with the same function of structural optimization, as described above.
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